What are Recombinant vaccine drugs?

Recombinant vaccine drugs are pharmacologic agents that share a common mechanism (typically targeting Human papillomavirus (HPV) types 6, 11, 16, 18, 31, 33, 45, 52, 58). 8 are currently marketed, with 9 more in clinical development.

What are the marketed Recombinant vaccine drugs?

Marketed Recombinant vaccine drugs include Recombinant Human Papillomavirus Nonavalent Vaccine, HPV9v, RECOMBIVAX HB™, EngerixB, GlaxoSmithKline Vaccines, Engerix-B vaccine, Hepatitis B recombinant vaccine.

Recombinant vaccine

8 marketed 9 in Phase 3

This page covers all Recombinant vaccine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Human papillomavirus (HPV) types 6, 11, 16, 18, 31, 33, 45, 52, 58, Hepatitis B surface antigen (HBsAg), Human papillomavirus (HPV) types 6, 11, 16, 18.

Targets

Human papillomavirus (HPV) types 6, 11, 16, 18, 31, 33, 45, 52, 58 · Hepatitis B surface antigen (HBsAg) · Human papillomavirus (HPV) types 6, 11, 16, 18 · Varicella-zoster virus (VZV) glycoproteins

Marketed (8)

Recombinant Human Papillomavirus Nonavalent Vaccine · National Cancer Institute (NCI) · Oncology / Immunology
A nonavalent vaccine that stimulates the immune system to produce antibodies against nine types of human papillomavirus (HPV types 6, 11, 16, 18, 31, 33, 45, 52, and 58) to prevent HPV-related cancers and diseases.
HPV9v · Fundacion SEIMC-GESIDA · Oncology / Immunology / Infectious Disease
HPV9v is a 9-valent human papillomavirus vaccine that stimulates immune responses against nine HPV types to prevent infection and HPV-related cancers.
RECOMBIVAX HB™ · Merck Sharp & Dohme LLC · Immunology / Infectious Disease
RECOMBIVAX HB is a recombinant hepatitis B vaccine that stimulates the immune system to produce antibodies against hepatitis B surface antigen (HBsAg), providing protection against hepatitis B virus infection.
EngerixB, GlaxoSmithKline Vaccines · University of British Columbia · Immunology
Engerix-B is a recombinant hepatitis B vaccine that stimulates the immune system to produce antibodies against hepatitis B surface antigen (HBsAg), providing protection against hepatitis B virus infection.
Engerix-B vaccine · GlaxoSmithKline · Immunology
Engerix-B stimulates the immune system to produce antibodies against hepatitis B surface antigen, providing protection against hepatitis B virus infection.
Hepatitis B recombinant vaccine · Pontificia Universidad Catolica de Chile · Immunology
This recombinant vaccine stimulates the immune system to produce antibodies against hepatitis B surface antigen, providing protection against hepatitis B virus infection.
EngerixTM-B · GlaxoSmithKline · Immunology / Infectious Disease
Engerix-B is a recombinant hepatitis B vaccine that stimulates the immune system to produce antibodies against hepatitis B surface antigen, providing protection against hepatitis B virus infection.
Engerix B · Crucell Holland BV · Immunology
Engerix B is a recombinant hepatitis B vaccine that stimulates the immune system to produce antibodies against hepatitis B surface antigen (HBsAg).

Phase 3 pipeline (9)

HepavaxGene (thiomersal free) · Crucell Holland BV · Immunology / Infectious Disease
HepavaxGene is a recombinant hepatitis B vaccine that stimulates the immune system to produce antibodies against hepatitis B surface antigen.
Comparator: ENGERIX-B™ · Merck Sharp & Dohme LLC · Immunology / Infectious Disease
ENGERIX-B is a recombinant hepatitis B vaccine that stimulates the immune system to produce antibodies against hepatitis B surface antigen (HBsAg), providing protection against hepatitis B virus infection.
Engerix-BTM · GlaxoSmithKline · Immunology / Infectious Disease
Engerix-B is a recombinant hepatitis B vaccine that stimulates the immune system to produce antibodies against hepatitis B surface antigen (HBsAg), providing protection against hepatitis B virus infection.
GenHevac B Pasteur · ANRS, Emerging Infectious Diseases · Immunology / Infectious Disease
GenHevac B Pasteur is a recombinant hepatitis B vaccine that stimulates the immune system to produce antibodies against hepatitis B surface antigen.
Engerix TM · GlaxoSmithKline · Immunology / Infectious Disease
Engerix-B is a recombinant hepatitis B vaccine that stimulates the immune system to produce antibodies against hepatitis B surface antigen (HBsAg).
Gardasil ® (Merck & Co. Inc) · GlaxoSmithKline · Oncology / Immunology
Gardasil is a recombinant vaccine that stimulates the immune system to produce antibodies against human papillomavirus (HPV) types to prevent infection and associated cancers.
SIBP-02 · Shanghai Institute Of Biological Products · Immunology / Infectious Disease
SIBP-02 is a recombinant hepatitis B vaccine candidate designed to provide immunological protection against hepatitis B virus infection.
SIBP-01 · Shanghai Institute Of Biological Products · Immunology / Infectious Disease
SIBP-01 is a recombinant hepatitis B vaccine candidate designed to provide immunological protection against hepatitis B virus infection.
V920 Consistency Lot A · Merck Sharp & Dohme LLC · Immunology / Infectious Disease
V920 is a vaccine candidate designed to stimulate immune responses against varicella-zoster virus (VZV) to prevent herpes zoster and post-herpetic neuralgia.